Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China flag China · Delayed Price · Currency is CNY
36.42
-0.27 (-0.74%)
At close: Feb 13, 2026

SHA:688062 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,4421,1931,6512,49196.54305.17
Short-Term Investments
-35.8735.26---
Trading Asset Securities
40.093.7714.8860.12-242.74
Cash & Short-Term Investments
1,4821,2321,7012,55196.54547.92
Cash Growth
-6.52%-27.56%-33.32%2542.47%-82.38%1241.79%
Accounts Receivable
57.2938.3417.510.070.140.23
Other Receivables
127.38100.05112.2782.6533.0151.7
Receivables
184.67138.39129.7882.7333.1551.92
Inventory
198.56211.68159.379.0540.1134.79
Other Current Assets
79.85122.8457.4865.1274.9332.55
Total Current Assets
1,9451,7052,0482,778244.74667.18
Property, Plant & Equipment
2,0042,0531,9351,263811.64517.34
Long-Term Investments
93.9346.6641.9520.218.95-
Goodwill
118.77118.77118.77118.77118.77118.77
Other Intangible Assets
148.19152.81139.72161.31179.4191.5
Long-Term Deferred Charges
6.676.390.986.1312.7119.49
Other Long-Term Assets
210.45192.76170.98271.93209.07124.61
Total Assets
4,5274,2764,4554,6191,5951,639
Accounts Payable
144.53100.2362.3245.2139.6922.56
Accrued Expenses
74.09153.03138.1282.2557.5326.07
Short-Term Debt
1,219921.6209.27100.1410.8250.04
Current Portion of Long-Term Debt
264.56113.651.590.60.15-
Current Portion of Leases
-31.5226.9621.0218.83-
Current Income Taxes Payable
44.58-3.34---
Current Unearned Revenue
224.7736.0113.5236.6563.536.2
Other Current Liabilities
186.8185.67361.26159.2779.8561.97
Total Current Liabilities
2,1581,542816.39445.14270.41166.84
Long-Term Debt
948.761,006887.72492.12132.05-
Long-Term Leases
117.32142.97167.11160.57172.72-
Long-Term Unearned Revenue
30.1227.0710.5911.0311.471.61
Other Long-Term Liabilities
327.281.53----
Total Liabilities
3,5822,7201,8821,109586.65168.45
Common Stock
399.6399.6399.6399.6299.7299.7
Additional Paid-In Capital
5,7605,9595,9315,8122,4562,146
Retained Earnings
-5,393-4,795-3,751-2,698-1,743-973.1
Comprehensive Income & Other
5.085.084.81.56-2.6-1.75
Total Common Equity
761.11,5692,5843,5161,0111,471
Minority Interest
184.48-13.1-10.45-5.08-2.18-0.21
Shareholders' Equity
945.581,5562,5733,5111,0091,470
Total Liabilities & Equity
4,5274,2764,4554,6191,5951,639
Total Debt
2,5492,2161,293774.45334.5850.04
Net Cash (Debt)
-1,067-983.91408.41,777-238.03497.88
Net Cash Growth
---77.01%--1119.24%
Net Cash Per Share
-2.67-2.461.024.54-0.791.75
Filing Date Shares Outstanding
399.4399.6399.6399.6299.7299.7
Total Common Shares Outstanding
399.4399.6399.6399.6299.7299.7
Working Capital
-212.99163.471,2312,333-25.68500.34
Book Value Per Share
1.913.936.478.803.374.91
Tangible Book Value
494.141,2972,3253,236712.641,160
Tangible Book Value Per Share
1.243.255.828.102.383.87
Buildings
-753.02181.833.063.063.06
Machinery
-1,206653.69440.39420.08394.01
Construction In Progress
-240.871,131804.49313.24192.2
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.